| Literature DB >> 32971797 |
Marina Kostić1, Marija Ivanov1, Ângela Fernandes2, José Pinela2, Ricardo C Calhelha2, Jasmina Glamočlija1, Lillian Barros2, Isabel C F R Ferreira2, Marina Soković1, Ana Ćirić1.
Abstract
This study explored the biological properties of three wild growing Russula species (R. integra, R. rosea, R. nigricans) from Serbia. Compositional features and antioxidant, antibacterial, antibiofilm, and cytotoxic activities were analyzed. The studied mushroom species were identified as being rich sources of carbohydrates and of low caloric value. Mannitol was the most abundant free sugar and quinic and malic acids the major organic acids detected. The four tocopherol isoforms were found, and polyunsaturated fatty acids were the predominant fat constituents. Regarding phenolic compounds, P-hydroxybenzoic and cinnamic acids were identified in the prepared methanolic and ethanolic extracts, which displayed antioxidant activity through the inhibition of thiobarbituric acid reactive substances (TBARS) formation and oxidative hemolysis; the highest activity was attributed to the R. nigricans ethanolic extract. This is the first report on the antibacterial and antibiofilm potential of the studied species, with the most promising activity observed towards Streptococcus spp. (0.20-0.78 mg/mL as the minimal inhibitory concentration, MIC). The most promising cytotoxic effect was caused by the R. integra methanolic extract on non-small cell lung cancer cells (NCI-H460). Therefore, due to the observed in vitro bioactive properties, the studied mushrooms arise as a source of functional ingredients with potential to be used in novel nutraceutical and drug formulations, which can be used in the treatment of various diseases and health conditions.Entities:
Keywords: Russula integra; Russula nigricans; Russula rosea; antibacterial agents; antibiofilm activity; antioxidant activity; cytotoxicity; functional ingredients
Mesh:
Substances:
Year: 2020 PMID: 32971797 PMCID: PMC7570958 DOI: 10.3390/molecules25184336
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Nutritional value and free sugars and organic acids composition of the studied mushrooms (mean ± SD, n = 3).
| Constituent |
|
|
|
|---|---|---|---|
| Nutritional Value (g/100 g dw) | |||
| Fat | 1.12 ± 0.04 b | 0.84 ± 0.01 c | 1.70 ± 0.06 a |
| Protein | 21.3 ± 0.5 a | 12.2 ± 0.01 c | 19.33 ± 0.5 b |
| Ash | 5.19 ± 0.04 a | 4.9 ± 0.01 b | 3.71 ± 0.08 c |
| Carbohydrates | 72.4 ± 0.3 c | 82.03 ± 0.1 a | 75.26 ± 0.4 b |
|
|
|
| |
| Free Sugars (g/100 g dw) | |||
| Fructose | 0.347 ± 0.002 b | nd | 0.39 ± 0.01 a |
| Mannitol | 14.6 ± 0.3 c | 25.8 ± 0.3 b | 34 ± 1 a |
| Trehalose | 0.202 ± 0.004 b | nd | 7.2 ± 0.5 a |
|
|
|
|
|
| Organic Acids (g/100 g dw) | |||
| Oxalic acid | 0.110 ± 0.003 b | 1.70 ± 0.01 a | tr |
| Quinic acid | 1.56 ± 0.03 b | nd | 11.26 ± 0.01 a |
| Malic acid | 1.29 ± 0.02 b | 2.06 ± 0.09 a | 0.60 ± 0.01 c |
| Citric acid | nd | nd | nd |
| Fumaric acid | 0.080 ± 0.001 a | tr | 0.020 ± 0.001 b |
|
|
|
|
|
tr—traces; nd—not detected; Different letters in the same row indicate significant differences between the means according to Tukey’s HSD test at p = 0.05; The bold indicate the total cumulative values.
Fatty acids and tocopherols composition of the studied mushrooms (mean ± SD, n = 3).
| Constituent |
|
|
|
|---|---|---|---|
| C6:0 | nd | 0.39 ± 0.02 | nd |
| C8:0 | 0.12 ± 0.01 a | 0.085 ± 0.001 b | 0.042 ± 0.001 c |
| C10:0 | 0.093 ± 0.008 c | 0.197 ± 0.008 a | 0.159 ± 0.007 b |
| C12:0 | 2.20 ± 0.03 a | nd | 0.079 ± 0.05 b |
| C14:0 | 2.53 ± 0.04 a | 0.61 ± 0.02 b | 0.241 ± 0.006 c |
| C14:1 | 0.126 ± 0.006 | nd | nd |
| C15:0 | 1.1 ± 0.1 a | 0.33 ± 0.01 b | 0.35 ± 0.01 b |
| C16:0 | 16.6 ± 0.2 a | 12.0 ± 0.3 b | 8.8 ± 0.3 c |
| C16:1 | 1.55 ± 0.01 a | nd | 0.80 ± 0.01 b |
| C17:0 | 0.572 ± 0.006 b | 0.88 ± 0.03 a | 0.127 ± 0.001 c |
| C18:0 | 6.57 ± 0.02 c | 36.3 ± 0.5 a | 7.8 ± 0.3 b |
| C18:1 n9c | 21.85 ± 0.04 c | 35.74 ± 0.06 a | 27.1 ± 0.1 b |
| C18:2 n6c | 38.2 ± 0.2 b | 13.39 ± 0.06 c | 52.0 ± 0.7 a |
| C18:3n3 | 1.45 ± 0.03 a | nd | 0.061 ± 0.001 b |
| C18:3n6 | 3.27 ± 0.09 | nd | nd |
| C20:0 | 1.98 ± 0.01 a | nd | 0.210 ± 0.004 b |
| C20:1 | 0.082 ± 0.001 b | nd | 0.247 ± 0.002 a |
| C20:2 | 0.58 ± 0.03 a | nd | 0.11 ± 0.01 b |
| C20:3n3 | nd | nd | nd |
| C20:3n6 | 0.274 ± 0.001 | nd | nd |
| C20:5n3 | nd | nd | nd |
| C22:0 | nd | nd | 0.264 ± 0.003 |
| C22:1 | 0.21 ± 0.01 a | nd | 0.16 ± 0.01 b |
| C22:1n9 | nd | nd | nd |
| C22:2 | nd | nd | 0.207 ± 0.001 |
| C23:0 | 0.149 ± 0.006 a | nd | 1.17 ± 0.06 a |
| C24:0 | 0.425 ± 0.006 a | nd | 0.16 ± 0.01 b |
| C24:1 | nd | nd | nd |
| Total SFA (% of total FA) | 32.4 ± 0.3 b | 50.9 ± 0.1 a | 19.4 ± 0.6 c |
| Total MUFA (% of total FA) | 23.81 ± 0.04 c | 35.74 ± 0.06 a | 28.3 ± 0.1 b |
| Total PUFA (% of total FA) | 43.8 ± 0.3 b | 13.39 ± 0.06 c | 52.3 ± 0.7 a |
| α-Tocopherol | 13.1 ± 0.4 c | 19.5 ± 0.3 b | 100 ± 3 a |
| β-Tocopherol | 15.8 ± 0.8 | nd | nd |
| γ-Tocopherol | 766 ± 2 | nd | nd |
| δ-Tocopherol | 15.7 ± 0.4 b | nd | 42 ± 4 a |
|
|
|
|
|
nd—not detected; Different letters in the same row indicate significant differences between the means according to Tukey’s HSD test at p = 0.05; The bold indicate the total cumulative values.
Phenolic and cinnamic acids composition of the studied mushroom extracts (µg/g of extract) (mean ±SD, n = 3).
| Cinnamic Acid | ||
|---|---|---|
| RIM | nd | nd |
| RIE | nd | nd |
| RRM | nd | 20.0 ± 0.1 |
| RRE | nd | 89 ± 2 |
| - | <0.001 | |
| RNM | nd | nd |
| RNE | 101 ± 5 | nd |
nd—not detected; RIM—R. integra methanolic extract; RIE—R. integra ethanolic extract; RRM—R. rosea methanolic extract; RRE—R. rosea ethanolic extract; RNM—R. nigricans methanolic extract; RNE—R. nigricans ethanolic extract. Comparison of means of RRM and RRE was performed with Student’s t-test at p = 0.05.
Antioxidant properties of the studied extracts (mean ±SD, n = 3).
| Extract | OxHLIA (IC50, µg/mL) | TBARS (IC50, µg/mL) | ||
|---|---|---|---|---|
| Δ | Δ | Δ | ||
| RIM | 111 ± 4 a | na | na | 1720 ± 5 a |
| RIE | 23 ± 1 b | 69 ± 2 | 139 ± 3 | 960 ± 22 b |
| RRM | na | na | na | 92 ± 4 e |
| RRE | na | na | na | 116 ± 4 d |
| RNM | 9.1 ± 0.7 c | na | na | 120 ± 22 c |
| RNE | 1.02 ± 0.07 c | na | na | 17 ± 2 f |
| Trolox | 3.1 ± 0.3 | 8.1 ± 0.2 | 20.6 ± 0.7 | 19.6 ± 0.1 |
IC50—Extract concentration required to protect half of the erythrocyte population for a certain Δt in the OxHLIA assay or corresponding to 50% of antioxidant activity in the TBARS assay; na: no antihaemolytic activity. Different letters in the same column indicate significant differences between the means according to Tukey’s HSD test at p = 0.05. RIM—R. integra methanolic extract; RIE—R. integra ethanolic extract; RRM—R. rosea methanolic extract; RRE—R. rosea ethanolic extract; RNM—R. nigricans methanolic extract; RNE—R. nigricans ethanolic extract.
Antibacterial activity of Russula spp. extracts (mg/mL).
| Bacteria | RIM | RIE | RRM | RRE | RNM | RNE | Amoxicillin + Clavulanic Acid | Cefixime | |
|---|---|---|---|---|---|---|---|---|---|
|
| MIC | 0.78 | 3.12 | 0.20 | 0.39 | 0.78 | 3.12 | 0.0002 | 0.002 |
| MBC | 1.56 | 6.25 | 0.39 | 0.78 | 1.56 | 6.25 | 0.0004 | 0.003 | |
|
| MIC | 3.12 | 0.78 | 3.12 | 0.39 | 1.56 | 1.56 | 0.007 | 0.002 |
| MBC | 6.25 | 1.56 | 6.25 | 0.78 | 3.12 | 3.12 | 0.014 | 0.003 | |
|
| MIC | 3.12 | 1.56 | 3.12 | 0.78 | 1.56 | 1.56 | 0.007 | 0.002 |
| MBC | 6.25 | 3.12 | 6.25 | 1.56 | 3.12 | 3.12 | 0.014 | 0.004 | |
|
| MIC | 1.56 | 3.12 | 6.25 | 0.78 | 1.56 | 3.12 | 0.028 | 0.0002 |
| MBC | 3.12 | 6.25 | 12.50 | 1.56 | 3.12 | 6.25 | 0.056 | 0.0004 | |
|
| MIC | 3.12 | 6.25 | 3.12 | 6.25 | 0.78 | 6.25 | 0.0002 | 0.0002 |
| MBC | 6.25 | 12.50 | 6.25 | 12.50 | 1.56 | 12.50 | 0.0004 | 0.0004 | |
|
| MIC | 3.12 | 6.25 | 0.39 | 0.20 | 3.12 | 3.12 | 0.007 | 0.0002 |
| MBC | 6.25 | 12.50 | 0.78 | 0.39 | 6.25 | 6.25 | 0.014 | 0.0004 | |
|
| MIC | 0.39 | 0.78 | 6.25 | 3.12 | 3.12 | 3.12 | 0.0004 | 0.002 |
| MBC | 0.78 | 1.56 | 12.50 | 6.25 | 6.25 | 6.25 | 0.001 | 0.003 | |
|
| MIC | 3.12 | 6.25 | 0.78 | 0.39 | 1.56 | 1.56 | 0.004 | 0.003 |
| MBC | 6.25 | 12.50 | 1.56 | 0.78 | 3.12 | 3.12 | 0.01 | 0.006 | |
|
| MIC | 0.78 | 0.78 | 1.56 | 0.78 | 3.12 | 1.56 | 0.001 | 0.013 |
| MBC | 1.56 | 1.56 | 3.12 | 1.56 | 6.25 | 3.12 | 0.002 | 0.027 | |
|
| MIC | 0.78 | 3.12 | 0.78 | 3.12 | 0.39 | 3.12 | 0.0004 | 0.0008 |
| MBC | 1.56 | 6.25 | 1.56 | 6.25 | 0.78 | 6.25 | 0.001 | 0.004 | |
|
| MIC | 6.25 | 6.25 | 3.12 | 3.12 | 6.25 | 6.25 | 0.01 | 0.013 |
| MBC | 12.50 | 12.50 | 6.25 | 6.25 | 12.50 | 12.50 | 0.014 | 0.027 | |
|
| MIC | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 | 6.25 | 0.001 | 0.003 |
| MBC | >12.50 | >12.50 | >12.50 | >12.50 | >12.50 | 12.50 | 0.002 | 0.006 | |
|
| MIC | >12.50 | 7.50 | >12.50 | >12.50 | >12.50 | 7.50 | 0.004 | 0.002 |
| MBC | >12.50 | >12.50 | >12.50 | >12.50 | >12.50 | >12.50 | 0.007 | 0.003 | |
|
| MIC | 6.25 | 6.25 | 3.12 | 6.25 | 6.25 | 3.12 | 0.001 | 0.003 |
| MBC | 12.50 | 12.50 | 6.25 | 12.50 | 12.50 | 6.25 | 0.002 | 0.006 | |
|
| MIC | >12.50 | 3.12 | 6.25 | 6.25 | 3.12 | 1.56 | 0.028 | 0.003 |
| MBC | >12.50 | 6.25 | 12.50 | 12.50 | 6.25 | 3.12 | 0.056 | 0.007 | |
|
| MIC | >12.50 | 12.50 | >12.50 | 12.50 | 12.50 | 6.25 | 0.003 | 0.003 |
| MBC | >12.50 | >12.50 | >12.50 | >12.50 | >12.50 | 12.5 | 0.007 | 0.006 |
MIC—minimal inhibitory concentration; MBC—minimal bactericidal concentration; RIM—R. integra methanolic extract; RIE—R. integra ethanolic extract; RRM—R. rosea methanolic extract; RRE—R. rosea ethanolic extract; RNM—R. nigricans methanolic extract; RNE—R. nigricans ethanolic extract.
Figure 1(A) Inhibition of S. aureus biofilm formation after treatment with MICs and subMICs of R. integra, R. rosea, and R. nigricans extracts. (B) Destruction of S. aureus 24 h preformed biofilm after 30 s treatment with MBC of R. integra, R. rosea, and R. nigricans extracts. Results are expressed as inhibition percentage, average value of three replicates ± SD.
Cytotoxicity and antitumor activity of the studied samples (GI50 values μg/mL, mean ±SD).
| Cytotoxicity to Non-Tumor Cell Line | Cytotoxicity to Tumor Cell Lines | ||||
|---|---|---|---|---|---|
| PLP2 (porcine liver primary culture) | HeLa (cervical carcinoma) | HepG2 (hepatocellular carcinoma) | MCF-7 (breast carcinoma) | NCI-H460 (non-small cell lung cancer) | |
| RIM | >400 | 338 ± 13 | >400 | 253 ± 1 | 236 ± 3 |
| RIE | >400 | >400 | >400 | 305 ± 12 | 281 ± 9 |
| RRM | >400 | 333 ± 7 | 303 ± 8 | 381 ± 16 | 323 ± 7 |
| RRE | >400 | >400 | >400 | >400 | >400 |
| RNM | >400 | >400 | 372 ± 23 | >400 | >400 |
| RNE | >400 | >400 | >400 | >400 | >400 |
| Ellipticine | 2.3 ± 0.1 | 0.91 ± 0.1 | 1.10 ± 0.09 | 1.21 ± 0.02 | 1.03 ± 0.09 |
GI50 values correspond to the sample concentration responsible for 50% inhibition of growth in a primary culture of liver cells-PLP2 or in human tumor cell lines. RIM—R. integra methanolic extract; RIE—R. integra ethanolic extract; RRM—R. rosea methanolic extract; RRE—R. rosea ethanolic extract; RNM—R. nigricans methanolic extract; RNE—R. nigricans ethanolic extract.